• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Behaviour of influenza A viruses differentially-expressing segment 2 gene products in vitro and in vivo

tetano

Editor, Senior Moderator
J Gen Virol. 2011 Dec 21. [Epub ahead of print]
Behaviour of influenza A viruses differentially-expressing segment 2 gene products in vitro and in vivo.
Tauber S, Ligertwood Y, Quigg-Nichol M, Dutia B, Elliott R.
Source

University of St Andrews, North Haugh, Fife, UK;
Abstract

The influenza A virus genome comprises 8 segments of negative-sense RNA that code for up to 12 proteins. RNA segment 2 encodes three proteins, PB1, PB1-F2 and N40, that are translated from the same mRNA by ribosomal leaky scanning and reinitiation. PB1 is a subunit of the trimeric viral RNA polymerase. PB1-F2 has been reported to be a potential virulence factor, and shown to be involved in a number of activities including induction of apoptosis, regulation of viral replication and modulation of the immune response. No function has yet been ascribed to N40 which represents an N-terminally deleted form of PB1. Previous studies on PB1-F2 function mainly used viruses genetically engineered to prevent PB1-F2 expression by mutation of the PB1-F2 start codon. However, ablation of the start codon was shown to increase the expression level of the downstream protein N40. In the present study we generated recombinant A/WSN/33 viruses carrying different combinations of PB1-F2 and N40 knockout mutations. Over-expression of N40 in a PB1-F2 deficient background had a detrimental effect on virus growth in vitro and in vivo. However, ablation of PB1-F2 or N40 expression individually was not disadvantageous for the virus. Primer extension analyses revealed an increase in vRNA production by viruses that over-expressed N40. Our data suggest that the observed attenuation of mutant viruses in vitro and in vivo results from these changes in transcription and replication.

PMID:
22190016
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/22190016
 
Back
Top Bottom